Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review.

Autor: Salvi V; Department of Mental Health and Addiction, ASST Crema, L.go Ugo Dossena 2, 26013 Crema, CR, Italy. Electronic address: virginiosalvi@gmail.com., Tripodi B; Department of Mental Health and Addiction, ASST Crema, L.go Ugo Dossena 2, 26013 Crema, CR, Italy., Cerveri G; Department of Mental Health and Addiction, ASST Lodi, Via Mosè Bianchi 26, 26900 Lodi, Italy., Migliarese G; Department of Mental Health and Addiction, ASST Pavia, C.so Milano 19, 27029 Vigevano, PV, Italy., Bertoni L; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Nibbio G; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Barlati S; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Vita A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Mencacci C; Director Emeritus, Department of Neurosciences-Mental Health, ASST Fatebenefratelli-Sacco, Milan, Italy.

Publikováno v: Schizophrenia research [Schizophr Res] 2024 Dec; Vol. 274, pp. 78-89. Date of Electronic Publication: 2024 Sep 11.

Characteristics and health care resources utilisation of patients starting treatment with second generation antipsychotics: Italian real-world evidence study

Autor: Cerveri, G. ¹, Mencacci, C. ², Ruggieri, A. ³, Pergoraro, V. ⁴, Bagatin, C. ⁵, Barzaghi, S. ⁴, Lovera, A. ⁶, Gabarda, I. ⁶, Comandini, A. ⁶, Vergallo, A. ⁶, Cattaneo, A. ⁷

Publikováno v: In Neuroscience Applied 2024 3 Supplement 2

Understanding the potential of digital therapies in implementing the standard of care for depression in Europe.

Autor: Courtet P; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital CHU Montpellier, Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France., Amiot O; GH Paul Guiraud, Boulogne Billancourt, France., Baca-Garcia E; Department of Psychiatry, University Hospital Jimenez Diaz Foundation, Madrid, Spain.; Department of Psychiatry, University Hospital Rey Juan Carlos, Mostoles, Spain.; Department of Psychiatry, General Hospital of Villalba, Madrid, Spain.; Department of Psychiatry, University Hospital Infanta Elena, Valdemoro, Spain.; Department of Psychiatry, Madrid Autonomous University, Madrid, Spain.; Centro de Investigacion en Salud Mental (CIBERSAM), Carlos III Institute of Health, Madrid, Spain.; Department of Psychiatry, Centre Hospitalier Universitaire de Nîmes, Nîmes, France., Bellardita L; Maggiolina and Città Studi Center, Milan, Italy., Cerveri G; Department of Mental Health, Addiction Hospital, Lodi, Italy., Clair AH; Institut du Cerveau - Paris Brain Institute - ICM, Sorbonne Université, INSERM, CNRS, Paris, France., De Leo D; Department of Psychology, Primorska University, Koper, Slovenia., Drapier D; Centre Hospitalier Guillaume régnier, Pôle Hospitalo universitaire de psychiatrie, CIC Rennes INSERM, Rennes, France., Fakra E; Saint Étienne University Hospital, University Jean Monnet, Saint Étienne, France.; PsyR2 Team, Centre de Recherche en Neurosciences de Lyon (CRNL), INSERM U1028, CNRS UMR 5292, Université Jean Monnet Saint Etienne, Université Lyon 1, Saint-Étienne, France., Gheysen F; Compassionate Mind Foundation France, Caen, France., Giner L; Department of Psychiatry, Universidad de Sevilla, Seville, Spain., Gonzalez-Pinto A; BIOARABA, Department of Psychiatry, Hospital Universitario de Alava, UPV/EHU, CIBERSAM, Vitoria, Spain., Gussoni G; Clinical Research Department, Italian Scientific Society of Internal Medicine (FADOI), Milan, Italy., Haffen E; UR LINC, Service de psychiatrie de l'adulte, CIC-1431 INSERM, CHU de Besançon, Université de Franche-Comté, Besançon, France., Lecardeur L; DueL, Nice, France., Mayoral-Cleries F; Department of Mental Health, Regional University Hospital of Málaga, Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain., Mennini FS; EEHTA-CEIS, DEF Department, Faculty of Economic, University of Rome Tor Vergata, Roma, Italy.; Institute for Leadership and Management in Health, Kingston University, London, UK., Sáiz PA; Centro de Investigacion en Salud Mental (CIBERSAM), Carlos III Institute of Health, Madrid, Spain.; Department of Psychiatry, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), University of Oviedo, Oviedo, Spain.; Instituto de Neurociencias del Principado de Asturias (INEUROPA), Mental Health Services of the Principality of Asturias (SESPA), Oviedo, Spain., Vieta E; Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain., Hidalgo DA; Bipolar Disorders Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain., Volpe U; Clinical Psychiatry Unit, Department of Clinical Neurosciences, Università Politecnica delle Marche, Ancona, Italy.

Publikováno v: European psychiatry : the journal of the Association of European Psychiatrists [Eur Psychiatry] 2023 Oct 24; Vol. 66 (1), pp. e82. Date of Electronic Publication: 2023 Oct 24.

Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice.

Autor: Fiorillo A; Department of Psychiatry, University of Campania 'L. Vanvitelli', Naples, Italy., Cuomo A; Department of Psychiatry, University of Siena, Siena, Italy., Sampogna G; Department of Psychiatry, University of Campania 'L. Vanvitelli', Naples, Italy., Albert U; Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy; Azienda Sanitaria Integrata Giuliano-Isontina - ASUGI, UCO Clinica Psichiatrica, Trieste, Italy., Calò P; Department of Mental Health, Azienda Sanitaria Integrata Giuliano-IsontinaLecce, Italy., Cerveri G; Department of Mental Health and Addiction, ASST Lodi, Lodi, Italy., De Filippis S; Neuropsychiatric Clinic, Villa Von Siebenthal, Genzano di Roma, Italy., Masi G; Scientific Institute of Child Neurology and Psychiatry, IRCCS Stella Maris, Calambrone, Pisa, Italy., Pompili M; Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Serafini G; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Vita A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy., Zuddas A; Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy., Fagiolini A; Department of Psychiatry, University of Siena, Siena, Italy.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Nov; Vol. 23 (16), pp. 1801-1818.

Analisi di costo-utilità probabilistica di lurasidone rispetto allo standard di cura in pazienti con schizofrenia in Italia

Autor: Mennini, F, Rossi, D, Bini, C, Rotundo, M, Cerveri, G, Diadema, E, Marcellusi, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3667::95b7ccf5355769106e816db5da1648b6
http://hdl.handle.net/2108/256284